Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Autor: Adlhoch C; European Centre for Disease Prevention and Control (ECDC), Gustav III:s boulevard 40, 169 73, Solna, Sweden. Electronic address: cornelia.adlhoch@ecdc.europa.eu., Manďáková Z; National Institute of Public Health, Prague, Czech Republic. Electronic address: zdenka.mandakova@szu.cz., Ethelberg S; Statens Serum Institut, Copenhagen, Denmark. Electronic address: SET@ssi.dk., Epštein J; Health Board, Tallinn, Estonia. Electronic address: Jevgenia.Epstein@terviseamet.ee., Rimhanen-Finne R; National Institute for Health and Welfare (THL), Helsinki, Finland. Electronic address: ruska.rimhanen-finne@thl.fi., Figoni J; Santé Publique France, Saint-Maurice, France. Electronic address: Julie.FIGONI@santepubliquefrance.fr., Baylis SA; Paul-Ehrlich-Institut (PEI), Langen, Germany. Electronic address: Sally.Baylis@pei.de., Faber M; Robert Koch-Institut, Berlin, Germany. Electronic address: FaberM@rki.de., Mellou K; Hellenic Public Health Organization, Athens, Greece. Electronic address: kmellou@gmail.com., Murphy N; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: niamh.murphy@hse.ie., O'Gorman J; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: joanne.ogorman4@hse.ie., Tosti ME; Istituto Superiore di Sanità, Rome, Italy. Electronic address: mariaelena.tosti@iss.it., Ciccaglione AR; Istituto Superiore di Sanità, Rome, Italy. Electronic address: annarita.ciccaglione@iss.it., Hofhuis A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: agnetha.hofhuis@rivm.nl., Zaaijer H; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands. Electronic address: h.zaaijer@sanquin.nl., Lange H; Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Heidi.Lange@fhi.no., de Sousa R; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal. Electronic address: rita.sousa@insa.min-saude.pt., Avellón A; Viral Hepatitis Reference and Research Laboratory National Center of Microbiology Carlos III Health Institute, Madrid, Spain. Electronic address: aavellon@isciii.es., Sundqvist L; The Public Health Agency of Sweden (Folkhälsomyndigheten), Stockholm, Sweden. Electronic address: lena.sundqvist@folkhalsomyndigheten.se., Said B; Public Health England, London, United Kingdom. Electronic address: bengu.said@phe.gov.uk., Ijaz S; Public Health England, London, United Kingdom. Electronic address: Samreen.Ijaz@phe.gov.uk.
Jazyk: angličtina
Zdroj: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2019 Nov; Vol. 120, pp. 63-67. Date of Electronic Publication: 2019 Sep 19.
DOI: 10.1016/j.jcv.2019.09.005
Abstrakt: Background: Hepatitis E virus (HEV) infection is not notifiable at EU/EEA level, therefore surveillance relies on national policies only. Between 2005 and 2015, more than 20,000 cases were reported in EU/EEA countries. HEV testing is established in 26 countries and 19 countries sequence HEV viruses.
Objective and Study Design: WHO's European Action plan for viral hepatitis recommends harmonised surveillance objectives and case definitions. ECDC's HEV expert group developed minimal and optimal criteria for national hepatitis E surveillance to support EU/EEA countries in enhancing their capacity and to harmonise methods.
Results: The experts agreed that the primary objectives of national surveillance for HEV infections should focus on the basic epidemiology of the disease: to monitor the incidence of acute cases and chronic infections. The secondary objectives should be to describe viral phylotypes or subtypes and to identify potential clusters/outbreaks and possible routes of transmission. Seventeen of 20 countries with existing surveillance systems collect the minimal data set required to describe the epidemiology of acute cases. Eleven countries test for chronic infections. Twelve countries collect data to identify potential clusters/outbreaks and information on possible routes of transmission.
Discussion: Overall, the majority of EU/EEA countries collect the suggested data and meet the outlined requirements to confirm an acute case.
(Copyright © 2019. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: